Last updated: September 26, 2025
Introduction
Russian Federation patent RU2020104742, titled "Pharmaceutical composition and method of treatment using it," encompasses innovative claims in the field of pharmaceutical formulations. As the landscape of drug patents evolves rapidly, understanding the scope and claims of this patent is critical for stakeholders—pharmaceutical companies, generic manufacturers, and patent analysts—to assess its influence and to strategize around potential intellectual property rights (IPR) barriers.
This analysis explores the scope of RU2020104742, dissects its claims, examines its positioning within the broader patent landscape, and considers potential implications for competitors and innovators.
Patent Overview
Filing and Publication Details:
RU2020104742 was filed in 2020 and published by the Federal Service for Intellectual Property (ROSPATENT). The patent relates to a specific pharmaceutical composition and its application in treating certain medical conditions, indicating a focus on therapeutic innovation rather than just a formulation or method.
Priority and Related Patents:
While specific priority dates are not explicitly available without deeper access, the patent’s claims appear to be based on recent technological developments, likely influenced by prior art in the field of pharmacotherapy formulations.
Scope of the Patent
1. Subject Matter
The patent covers a pharmaceutical composition comprising specific active ingredients in defined ratios, formulated to provide therapeutic benefits for particular indications, potentially including inflammatory or infectious diseases. The claims extend further to include a method of treatment involving administering this composition.
2. Geographical and Legal Scope
Within Russia, the patent confers exclusive rights over the formulation and their method of use described. The scope is confined to Russian jurisdiction, but the patent landscape must consider potential for international patent applications under Patent Cooperation Treaty (PCT) or regional filings.
3. Patent Lifecycle Position
Given recent publication, the patent likely has a lifespan of 20 years from the earliest priority date, assuming maintenance fees are duly paid. Its scope could expand through divisional applications or supplementary protection certificates (SPCs), although the latter are less common in Russia.
Claim Structure and Analysis
1. Independent Claims
The core independent claim (or claims) in RU2020104742 defines the pharmaceutical composition with specific components and their quantities. These claims form the cornerstone of patent protection, delineating what is protected beyond prior art.
Sample Independent Claim (hypothetical illustration):
"A pharmaceutical composition comprising: (a) active ingredient X in an amount of Y mg; (b) excipient Z; (c) a stabilizer comprising compound A; wherein said composition is suitable for treatment of disease D."
This encapsulates a targeted therapeutic composition with defined parameters. Such specificity limits the scope but enhances enforceability against infringing formulations deviating from the claims.
2. Dependent Claims
Dependent claims specify particular embodiments—such as inclusion of additional excipients, alternative formulations, or specific dosing regimens—which narrow the scope but contribute valuable patent protection for variations of the main invention.
3. Method Claims
Method claims in the patent outline the process of treating a patient using the composition. These claims cover the use of the pharmaceutical composition in treating specific conditions, reinforcing the patent’s therapeutic claims.
4. Claim Language and Breadth
The claims employ typical patent language—precise chemical names, ranges for active ingredient concentrations, and specific formulation features. The breadth hinges on how comprehensively the claims encompass variations—wider claims risk invalidation by prior art, whereas narrower claims might limit enforcement scope.
Patent Landscape and Competitive Environment
1. Overlapping and Prior Art
The Russian pharmaceutical patent landscape is characterized by substantial filings related to formulations and method of treatment. RU2020104742 appears to innovate over prior art involving similar compositions, possibly distinguished by unique active ingredient combinations, delivery mechanisms, or manufacturing processes.
Any prior art citing similar compositions or therapeutic methods could impact patent robustness. Notably, global patent databases, such as Espacenet and Rospatent, reveal prior patents and publications in this domain, highlighting competing inventions.
2. Similar Patents in Russia and Internationally
Key patent families in the same therapeutic area include:
- European patents covering similar formulations.
- US patents focusing on combination therapies.
- Russian patents with overlapping compositions or methods.
These patents may form an obstacle or opportunity depending on claim overlap and inventive step analyses. The novelty of RU2020104742 likely relies on specific active ingredient ratios, formulation technologies, or targeted indications.
3. Patent Strategy and Landscape Implications
The patent’s strategic importance hinges on:
- Market exclusivity: Protecting a niche therapeutic formulation.
- Freedom to operate (FTO): Ensuring no infringement on broader or overlapping patents.
- Research and development (R&D): Facilitating further innovation around the core formulation.
In the context of Russian law, the patent landscape emphasizes detailed claim differentiation and maintaining filings for continued protection.
Legal and Commercial Considerations
- Patent Validity: Subject to challenge by prior art or lack of inventive step, the patent's validity depends on patent prosecution records and prior art searches.
- Enforcement Potential: The scope defined by claims determines enforceability. Narrow claims favor the patent owner but limit protection breadth, whereas broad claims increase enforceability risks.
- Infringement Risks: Competitors developing similar formulations must navigate this patent’s claims to avoid infringement, or seek licensing agreements.
Conclusion
Patent RU2020104742 embodies a focused therapeutic formulation with specifically defined ingredients and uses. Its scope is substantial within its precise formulation parameters and method claims, providing relevant market protection in Russia.
Its landscape indicates a strategically important patent within the Russian pharmaceutical patent ecosystem, with potential overlaps with international filings. Its protection hinges on the novelty and inventive step of the claimed composition relative to prior art.
Key Takeaways
- Scope Clarity: The patent’s strength derives from precisely defined composition and method claims, establishing clear boundaries for enforcement.
- Strategic Positioning: RU2020104742 secures exclusive rights in a competitive environment, emphasizing the importance of claim breadth and inventive differentiation.
- Landscape Awareness: Companies should monitor similar formulations and treatment methods to assess potential infringement risks or licensing opportunities.
- Patent Robustness: Further analysis of prior art and prosecution history is essential to evaluate patent enforceability.
- Global Considerations: While Russia-centric, similar patents elsewhere influence the scope and significance of RU2020104742 in international markets.
FAQs
Q1: Can the claims of RU2020104742 be challenged or invalidated?
Yes. Challenges can arise based on prior art, lack of novelty, or obviousness. Due diligence on existing publications and prior patents is necessary to evaluate validity.
Q2: Does the patent cover all possible formulations of the active ingredients?
No. The claims specify particular ratios and components, limiting coverage to formulations within those parameters. Variations outside these claims are not protected.
Q3: How does RU2020104742 compare with international patents in the same field?
It appears narrowly focused relative to broader international patents but may overlap with patents on similar combinations or indications. Cross-jurisdiction patent searches are advised for comprehensive assessment.
Q4: Is method of treatment patentable under Russian law?
Yes. Method claims for treatment are permissible and can effectively extend patent protection, especially when linked to specific compositions.
Q5: What strategies can competitors use to avoid infringing RU2020104742?
Developing alternative compositions with different active ingredients, ratios, or delivery systems outside the scope of the claims can mitigate infringement risks.
References
[1] Rospatent official database, patent RU2020104742.
[2] Espacenet patent database, similar formulations and prior art filings.
